Chun Seon Lyu

Chun Seon Lyu is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance drug stability and efficacy. With a total of two patents to his name, Lyu's work reflects a commitment to advancing medical science.

Latest Patents

Lyu's latest patents include a preparation containing a benzimidazole derivative. This novel formulation is designed for oral administration and includes a compound of Formula 1 or a pharmaceutically acceptable salt thereof, along with at least one disintegrant. The formulation exhibits excellent storage stability and effectively prevents a decline in dissolution rate, making it a valuable option for oral medications. Another significant patent is a stable pharmaceutical composition comprising solifenacin. This preparation includes solifenacin or a pharmaceutically acceptable salt, an antioxidant, and a binder, manufactured via direct compression. This method simplifies the manufacturing process compared to traditional wet granulation, resulting in improved content uniformity and mixing degree.

Career Highlights

Chun Seon Lyu has worked with prominent companies in the pharmaceutical industry, including Hk Inno.n Corporation and Cj Healthcare Corporation. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Lyu has collaborated with talented individuals such as Hyungsuk Lim and Sun Young Park. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Chun Seon Lyu's contributions to pharmaceutical innovations demonstrate his expertise and dedication to improving drug formulations. His patents reflect a significant advancement in the field, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.